Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

EAN 2017

24–27 June 2017 | Amsterdam, Netherlands

EAN 2017

24–27 June 2017 | Amsterdam, Netherlands
The neuropathology and genetics of ALS and FTD 1:38
The neuropathology and genetics of ALS and FTD
Manuela Neumann • 24 Jun 2017
Challenges of managing the neuropsychiatric symptoms of Alzheimer’s and vascular dementia 4:31
Challenges of managing the neuropsychiatric symptoms of Alzheimer’s and vascular dementia
Pasquale Calabrese • 24 Jun 2017
ALS and frontotemporal dementia: on a continuum or part of a spectrum of disorders? 3:31
ALS and frontotemporal dementia: on a continuum or part of a spectrum of disorders?
Manuela Neumann • 24 Jun 2017
ASL MRI as an early biomarker for Alzheimer’s disease 3:07
ASL MRI as an early biomarker for Alzheimer’s disease
M. Hale Alpsan Gökmen • 24 Jun 2017
Investigating physical activity and Alzheimer’s disease 1:02
Investigating physical activity and Alzheimer’s disease
Kristian Steen Frederiksen • 24 Jun 2017
APOE haplotypes, ACE insertion/deletion polymorphism and neuropsychiatric symptoms in Alzheimer’s 1:47
APOE haplotypes, ACE insertion/deletion polymorphism and neuropsychiatric symptoms in Alzheimer’s
Fabricio Ferreira De Oliveira • 24 Jun 2017
Angiotensin receptor blockers on cognitive function in Alzheimer’s disease 2:41
Angiotensin receptor blockers on cognitive function in Alzheimer’s disease
Fabricio Ferreira De Oliveira • 24 Jun 2017
A novel biomarker of Alzheimer’s disease progression: LTP-like cortical plasticity 3:11
A novel biomarker of Alzheimer’s disease progression: LTP-like cortical plasticity
Francesco Di Lorenzo • 24 Jun 2017
Challenges with comorbidities and dementia 1:24
Challenges with comorbidities and dementia
Dorota Religa • 24 Jun 2017
Cerebrospinal fluid (CSF) and imaging biomarkers for the differential diagnosis of dementia 1:06
Cerebrospinal fluid (CSF) and imaging biomarkers for the differential diagnosis of dementia
Philip Scheltens • 24 Jun 2017
Strategies for the prevention of vascular cognitive impairment 2:03
Strategies for the prevention of vascular cognitive impairment
Leonardo Pantoni • 24 Jun 2017
Outcome measures and comorbidities in dementia 0:49
Outcome measures and comorbidities in dementia
Dorota Religa • 24 Jun 2017
Pioglitazone for the treatment of Alzheimer’s disease 1:17
Pioglitazone for the treatment of Alzheimer’s disease
Daniela Galimberti • 24 Jun 2017
Risk factors for developing dementia 1:15
Risk factors for developing dementia
Daniela Galimberti • 24 Jun 2017
Dementia, it’s not only Alzheimer’s disease 3:40
Dementia, it’s not only Alzheimer’s disease
Antonio Federico • 24 Jun 2017
Cognitive performance stays stable in chronic kidney disease patients over a 2-year period 1:26
Cognitive performance stays stable in chronic kidney disease patients over a 2-year period
Janine Gronewold • 24 Jun 2017
The content of VJDementia is intended for healthcare professionals